Juno Therapeutics (JUNO) Posts Q4 Loss of $1.61/Share
Get Alerts JUNO Hot Sheet
Join SI Premium – FREE
Juno Therapeutics (NASDAQ: JUNO) reported Q4 EPS of ($1.61), $1.28 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Juno Therapeutics (JUNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share